Structural and functional abnormalities in the cerebral microvasculature have been observed in Alzheimer's disease (AD) patients and animal models. One cause of hypoperfusion is the thickening of the cerebrovascular basement membrane (CVBM) due to increased collagen-IV deposition around capillaries. This study investigated whether these and other alterations in the cerebrovascular system associated with AD can be prevented by longterm dietary supplementation with the antioxidant ubiquinol (Ub) stabilized with Kaneka QH P30 powder containing ascorbic acid (ASC) in a mouse model of advanced AD (3 × Tg-AD mice, 12 months old). Animals were treated from prodromal stages of disease (3 months of age) with standard chow without or with Ub + ASC or ASC-containing vehicle and compared to wild-type (WT) mice. The number of β-amyloid (Aβ) plaques in the hippocampus and entorhinal cortex was higher in female than in male 3 × Tg-AD mice. Extensive regions of hypoxia were characterized by a higher plaque burden in females only. This was abolished by Ub + ASC and, to a lesser extent, by ASC treatment. Irrespective of Aβ burden, increased collagen-IV deposition in the CVBM was observed in both male and female 3 × Tg-AD mice relative to WT animals; this was also abrogated in Ub + ASCand ASC-treated mice. The chronic inflammation in the hippocampus and oxidative stress in peripheral leukocytes of 3 × Tg-AD mice were likewise reversed by antioxidant treatment. These results provide strong evidence that long-term antioxidant treatment can mitigate plasma oxidative stress, amyloid burden, and hypoxia in the AD brain parenchyma.
Introduction
Evidence from recent studies suggests an association between Alzheimer's disease (AD) and chronic diseases such as cancer, diabetes, and cardiovascular diseases. Mitochondrial dysfunction, increased oxidative stress, and chronic brain hypoperfusion contribute to the disruption of the blood-brain barrier (BBB) and cause damage to brain parenchymal cells (De la Torre, 2012; Aliev et al., 2013; Aliev et al., 2014; Jabir et al., 2015; Ul Islam et al., 2017) . The vascular system of the AD brain shows a variety of histopathological features of the cerebral microvessels such as atrophic thin vessels, glomerular loop formations, fragmented vessels, thickening in the basement membrane of brain capillaries and ultrastructural modifications which can have serious physiological consequences (see (Farkas and Luiten, 2001 ) for a review of the morphological abnormalities). Kalaria reported a CVBM thickening due to collagen-IV deposition in human AD (Kalaria and Pax, 1995 ) that has been also described in the brain microvasculature andthe presence of the apolipoprotein E4 allele, lifestyles that increase the risk of cardiovascular disease, traumatic brain injury, and oxidative stress (Hayden et al., 2006; Mayeux and Stern, 2012; Scheltens et al., 2016) have been linked to AD. The transition from normal cognition to mild cognitive impairment (MCI) preceding AD is associated with reduced cerebral blood flow (CBF) (Maalikjy Akkawi et al., 2005; Dai et al., 2009; Wang et al., 2013; Lacalle-Aurioles et al., 2014; Mattsson et al., 2014) . Hypoxia results from cerebral hypoperfusion and plays an essential role in AD development by increasing β-amyloid (Aβ) production and deposition, Tau protein phosphorylation (Austin et al., 2011; Gao et al., 2013) , and the generation of reactive oxygen species (ROS) (Wahlster et al., 2013) . Oxidative damage is highest during the early stages of AD and declines with disease progression (Nunomura et al., 2001) , and has been shown to induce beta-secretase (BACE)1 expression and activity in vitro (Tamagno et al., 2002) . Reduced CBF causes hypoperfusion in the brain parenchyma and increases the expression of hypoxia inducible factor 1-α, which in turn leads to upregulation of BACE1 (Zhang et al., 2007; Guglielmotto et al., 2009 ). This results in Aβ accumulation in neurons and an increase in oxidative stress, which damages endothelial cells in a self-perpetuating cycle (Chami and Checler, 2012) . In fact, in 3 × Tg-AD mice-a widely used mouse model of AD-cerebrovascular volume is reduced at 11 months of age (Bourasset et al., 2009) . In humans, a decrease in CBF occurs prior to the onset of dementia (Iadecola, 2004; Ruitenberg et al., 2005) . Cerebrovascular blood volume directly depends on basement membrane thickness, which increases with AD progression in humans and in 3 × Tg-AD mice (Kalaria and Pax, 1995; Bourasset et al., 2009; Mehta et al., 2013a; Gonzalez-Marrero et al., 2015) .
Oxidative stress is a well-established dementia pathway and antioxidant therapies could counter oxidative stress by preventing or delaying AD. In human blood plasma ascorbate is an outstanding physiological antioxidant for protection against diseases and degenerative processes caused by oxidant stress (Frei et al., 1989) . It has been reported that ascorbate decreases β-amyloid generation and acetylcholinesterase activity and prevents endothelial dysfunction (Heo et al., 2013) . Coenzyme (Co) Q10, also known as ubiquinone, is a natural lipophilic antioxidant that acts as an electron carrier of the respiratory chain in mitochondria and widely distributed in the plasma membrane that participates in various cellular processes. CoQ10 is an effective lipid-soluble antioxidant at physiological concentrations, which provides a basis for antioxidant action either by direct reaction with radicals or by regeneration of tocopherol and ascorbate (Crane, 2001) . CoQ10 has been investigated for its therapeutic potential in cardiovascular diseases (Villalba et al., 2010; Gao et al., 2012) , and has been shown to improve endothelial cell function (Dai et al., 2011; Gao et al., 2012; Duran-Prado et al., 2014) . The neuroprotective effects of CoQ10 against Aβ-induced injury have also been examined in vitro (Li et al., 2005; Moreira et al., 2005) . We previously reported that pretreating endothelial cells with CoQ10 reduced Aβ entry and accumulation in mitochondria, which improved endothelial cell functioning in vitro (Duran-Prado et al., 2014) . Likewise, findings from animal models indicate that CoQ10 reduces intracellular Aβ deposition and the formation of extracellular plaques Yang et al., 2008; Yang et al., 2010) , while clinical evidence suggests a correlation between AD progression and oxidized/total CoQ10 ratio (Isobe et al., 2010) .
In the present study, we investigated whether long-term consumption of ubiquinol (Ub), the reduced form of CoQ10, could prevent vascular dysfunction (e.g., basement membrane and hypoperfusion) during AD progression. We demonstrate for the first time that female 3 × Tg-AD mice exhibit co-localization of hypoxic areas and Aβ plaques in the hippocampus and entorhinal cortex at advanced stages of the disease. Dietary Ub supplementation reduced hypoxia and Aβ burden and restored BACE1 level, cerebrovascular basement membrane (CVBM) thickness, and the number of microglia in male and female 3 × Tg-AD mice to values comparable to those of wild-type (WT) mice. The Ub formulation contained ascorbic acid (ASC) to prevent its natural oxidation. Interestingly, ASC alone also had neuroprotective effects, although they were less potent than those of Ub.
Materials and methods

Experimental animals and Ub and ASC supplementation
Three groups of 5 males and 5 females of 3 × Tg-AD mice were randomly assigned to either the standard chow (St) (Teklad Global; Envigo, Huntingdon, UK), standard chow supplemented with vehicle (10 mg ASC per 100 g of chow; ASC), or Ub-supplemented diet (60 mg Ub and 10 mg ASC per 100 g standard chow; Ub + ASC) groups. Ub was obtained from Kaneka (Pasadena, TX, USA). Five males and 5 females of WT C57BL/6 mice were fed with a standard diet. This strain intakes about 4 g chow/day (Bachmanov et al., 2002) , representing 2.4 mg/day of ubiquinol or 0.4 mg/day of ascorbate. The estimate human equivalent dose is 487.7 mg of ubiquinol for a 60 kg person a day or 81.2 mg/ day for ascorbate (Nair and Jacob, 2016) . Mice were kept group caged and maintained on the prescribed diet from the age of 3 months until euthanization at 12 months. The age at which supplementation was initiated was determined based on our previous observation that ADlike anxiety first appears in 3 × Tg-AD mice at 2 months of age (TorresLista et al., 2014) . Animal procedures were in accordance with European (Directive 2010/63/EU) and Spanish (RO 53/2013) legislation on the protection of animals used for scientific purposes. Experiments were previously approved by the Ethical Committee of Animal Research of the University of Castilla-La Mancha (CD-UCTR130181).
Behavioral assessment
At 12 months of age, long-term effects of treatments in the phobic response to a new environment were assessed by means of the corner test. Thus, neophobia to a new home-cage was assessed by introducing the animal into the centre of a new standard home cage (Makrolon, 35 × 45 × 25 cm) and counting the number of visited corners and the rearings during a period of 30 s. Latency of the first rearing was also recorded and the ratio of horizontal and vertical activity (visited corners/rearings) was calculated.
Animal perfusion and brain tissue processing
Animals were intraperitoneally injected with hypoxyprobe solution (pimonidazole-HCl) at a dosage of 60 mg/kg body weight 3 h before perfusion. Evans Blue dye (2% solution) was used as a BBB tracer and administered by intraperitoneal injection at a dose of 4 ml/kg. Animals were anesthetized with a mixture of ketamine hydrochloride (Ketolar, 1.5 ml/kg, 75 mg/kg; Parke-Oavis, Madrid, Spain) and xylazine (Xilagesic, 0.5 ml/kg, 10 mg/kg; Calier, Barcelona, Spain), and perfused with saline solution followed by 4% w/v paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.2). Approximately 150 μl of blood were collected by heart puncture into citrate tubes and immediately processed to quantify oxidative stress in leukocytes or stored at −80°C for biochemical analysis. Brains were post-fixed in 4% w/v paraformaldehyde for 24 h and then cryoprotected in 30% w/v sucrose. Brain sections (50 μm) were cut on a freezing microtome. Sequential tissue sections were collected in sets of eight.
Immunohistochemical analysis and imaging
Tissue sections were incubated for 24 h at 4°C in Tris-buffered saline containing 0.3% Triton X-100 with primary antibodies against collagen IV to visualize type IV collagen in the basement membrane (1:500; Sigma-Aldrich, St. Louis, MO, USA; SAB4200500); Aβ (1:200; Cell Signaling Technology, Danvers, MA, USA; #2454), which detects several isoforms of Aβ; Tau phosphorylated at serine 396 (1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA; sc-32275); Tau phosphorylated at threonine 205 to visualize p-Tau accumulations (1:500; Sigma-Aldrich, St. Louis, MO, USA; SAB4504561); BACE1, which is responsible for proteolytic processing of amyloid precursor protein (APP, 1:500; Abcam, Cambridge, MA, USA; AB-297419); NeuN a neuronal nuclei marker (1:250; Merck Millipore, Burlington, MA, USA;FCMAB317PE); GFAP (Glial Fibrillary Acidic Protein) an astrocyte marker (1:500; Sigma-Aldrich, St. Louis, MO, USA; SAB2500462); ionized calcium binding adaptor molecule (Iba)1 (C-20) (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA; sc-28530) a marker of microglia and inducible nitric oxide synthase (iNOS) NOS3 antibody (C-20) (1:500; Santa Cruz Biotechnology, sc-654), a marker of activated microglia. A fluorescein-conjugated mouse IgG1 monoclonal antibody that binds to protein, peptide and amino acid adducts of pimonidazole was used to visualize the hypoxic areas. Sections were incubated in Alexa 555 donkey anti-mouse, Alexa 647 donkey anti-goat, and Alexa 594 donkey anti-rabbit secondary antibodies (1:500; Life Technologies, Carlsbad, CA, USA). Controls without primary and secondary antibodies (the latter to monitor autofluorescence) were prepared using tissue sections from WT animals.
A total of six images from three different CA1 hippocampal sections or entorhinal cortex per animal were taken. Aβ deposition and hypoxia were quantified at 10× magnification with an Eclipse TiU inverted microscope (Nikon, Tokyo, Japan). The number of microglia was calculated at 10× magnification with an Eclipse TiU inverted microscope in hippocampal CA1 areas devoid of amyloid plaques. BACE1 levels and co-localization with NeuN and GFAP markers and co-localization between Iba1 and iNOS were quantified at 20× magnification using a Zeiss LSM 800 confocal microscope. The thickness of the CVBM was determined from pictures acquired at 63× magnification in a total of 20 small blood vessels of the hippocampal fissure in each animal with a Zeiss LSM 800 confocal microscope. Thickness was measured with ImageJ from 30 pixels linear ROIs traced in regions with a homogeneous staining, using background to determine beginning and end of the basement membrane. Brain sections were mounted in Vectashield medium with DAPI for fluorescence (Vector Laboratories, H-1200).
Representative low magnification pictures of brain coronal sections including β-amyloid plaques were obtained using a Cytation 5 equipment with a 10× objective. Briefly, series of 35 pictures were taken to cover each brain section in red (β-amyloid plaques) and blue (cell nuclei) channels. Pictures were stitched automatically with Cytation 5 software.
All calculations described in paragraphs above (signal intensity, area covered, thickness of the CVBM and co-localization for Aβ and hypoxia, BACE1 cell types and Iba1 and iNOS) were calculated from original 8-bit images using ImageJ software (National Institutes of Health, Bethesda, MD, USA).
Lipid extraction and CoQ quantification
Plasma CoQ9 and CoQ10 was extracted in hexane and quantified according to a previously described method (Bello et al., 2005) . Concentrations were calculated by integrating peak areas relative to external standards.
Evaluation of oxidative stress
Oxidative stress in leukocytes was determined using the buffy coat collected from mouse blood samples. Cells were resuspended in 2% w/v fetal bovine serum and 0.2% w/v 2′,7′-dichlorodihydrofluorescein diacetate (Life Technologies) in phosphate-buffered saline and incubated for 15 min at 37°C. H 2 O 2 concentration was determined with a fluorimeter (λex = 495/λem = 520 nm). Samples were then incubated with DAPI (Sigma-Aldrich) for 5 min and then analyzed with a fluorimeter (λex = 350/λem = 480 nm). Plasma lipid peroxidation was evaluated with the Lipid Peroxidation Malondialdehyde (MDA) Assay kit (Sigma-Aldrich); plasma oxidized low density lipoprotein (oxLDL) levels were determined using the Mouse oxLDL Enzyme-linked Immunosorbent Assay kit (Cusabio, College Park, MD, USA); and plasma protein carbonyl content was assessed using the OxiSelect Protein Carbonyl Fluorometric Assay (Cell Biolabs, San Diego, CA, USA) according to manufacturers' instructions.
Statistical analysis
GraphPad Prism v.6 software (GraphPad Inc., San Diego, CA, USA) was used for statistical analysis. Two-way analysis of variance was performed with sex and treatment as the two factors. Results are presented by sex when there were significant differences between males and females, whereas results for the main effect are reported together when there were no sex differences and no evidence of interactions. In these cases, data for both sexes were combined for statistical analysis and the Mann-Whitney U test was used to compare the means of different treatment groups. Data are presented as mean ± SEM. Differences were considered statistically significant at p < 0.05.
Results
Ubiquinol increases the CoQ10 levels but not the CoQ9 levels in plasma
We first quantified plasma CoQ10 and CoQ9 levels in 3 × Tg-AD and WT mice by high-performance liquid chromatography. Since there were no sex-related differences in CoQ9 and CoQ10 levels, data for both sexes were combined for subsequent analyses. There were no differences in the levels of CoQ9-the major form of ubiquinone in mice-among groups (Fig. 1A) . However, mice in the Ub + ASC group had 16-fold higher plasma levels of CoQ10 than the other groups (p < 0.001; Fig. 1B ), which was higher than previously reported values for supplementation with the oxidized form of ubiquinone (Lonnrot et al., 1996) . The presence of Kaneka QH P30 powder (ASC), which prevents Ub oxidation, had no effect on CoQ9 and CoQ10 levels.
Antioxidants suppress the levels of oxidative stress markers in plasma
In this study, we found no sex-related differences in the levels of oxidative stress markers in plasma, and therefore data for both sexes were combined for subsequent analyses. Animals consuming diets supplemented with antioxidants (ASC and Ub + ASC groups) showed decreased plasma levels of oxidative stress markers ( Fig. 2A, B) . MDA levels differed significantly between St and Ub + ASC groups (p < 0.01; Fig. 2A ), and carbonyl groups-another indicator of oxidative stress-were more abundant in the St group when compared to WT (p < 0.05). Treatment reduced the carbonyl protein levels but in higher extent in the Ub + ASC group (p < 0.001; Fig. 2B ). There were no differences in oxLDL level among groups (Fig. 2C) . Peripheral oxidative stress, measured as H 2 O 2 levels in leukocytes, was increased in 3 × Tg-AD mice (3.42-fold) compared to WT mice (WT vs St, Fig. 2D , p < 0.01) and it was reverted by treatments, showing similar betweengroups patterns with the levels of anxiety exhibited in a test for neophobia (Fig. 3) .
Behavioral effects of treatments
Peripheral oxidative stress in leukocytes increased in parallel with the increased levels of anxiety exhibited in the Corner test for neophobia (Fig. 3A-D) . In the naïve 3 × Tg-AD mice (St group), longer latency to perform the first rearing was recorded as compared to WT (p < 0.01; Fig. 3A ) and resulted in an increased horizontal/vertical activity ratio (p < 0.001; Fig. 3B ). While all groups of animals showed similar levels of visited corners (horizontal activity, Fig. 3 C) , the number of rearings (vertical exploratory activity) was found strongly abolished in the 3 × Tg-AD mice, when compared to wt (Fig. 3D , p < 0.001). Thus, all these behavioral results, indicative of increased neophobia, were rescued by ASC and/or Ub + ASC (p < 0.01 vs St group). ASC and Ub + ASC also reduced significantly the ROS levels as well as the level of neophobia, the reduction with Ub + ASC being higher (Fig. 3D , p < 0.01) compared to ASC alone (Fig. 3D , p < 0.05), showing a more robust-effect of Ub + ASC compared to ASC alone.
Antioxidants prevent CVBM thickening in 3 × Tg-AD mice
The BBB was not perturbed in any of the groups, as determined using Evans Blue dye (data not shown), which is in accordance with previous reports (Bourasset et al., 2009; Do et al., 2014) . We used Fig. 1 . Levels of coenzyme Q9 and coenzyme Q10 in the plasma of non-transgenic mice (WT) compared to 3 × Tg-AD mice fed with a standard (St), vehicle (ASC) and ubiquinol (Ub + ASC) supplemented diets. Each diet-group had 5 males and 5 females. Data from different diets are split by gender. The statistical analysis showed that the factor sex was not significant with the same diet. Thus, data for both sexes were fused for subsequent statistical analysis using the Mann Whitney test to compare between treatments. Mice were euthanized at the age of 12 months. No significantly differences in CoQ9 levels were found between groups Differences were regarded as statistically significant **p < 0.01. Fig. 2 . Levels of lipid peroxidation (A), protein oxidation (B), oxLDL (C) and oxidative stress in leucocytes (D) in mice euthanized at 12 month-old. Each diet-group had 5 males and 5 females. Data from different diets are split by gender. The statistical analysis showed that the factor sex was not significant with the same diet. Thus, data for both sexes were fused for subsequent statistical analysis using the Mann Whitney test to compare between treatments. Except for oxLDL, St mice showed higher levels of oxidative stress compared to wt, ASC and Ub + ASC. Differences were regarded as statistically significant *p < 0.05, **p < 0.01 and ***p < 0.001. collagen-IV immunolabeling to evaluate basal lamina thickness by fluorescence microscopy in the microvasculature of the hippocampal fissure at similar coronal levels to those in which Aβ plaques appear (Fig. S1 ). Since there were no sex-related differences, data for both sexes were combined for subsequent analyses. The CVBM was thinner in WT and Ub + ASC mice (0.546 ± 0.098 μm and 0.530 ± 0.018 μm, respectively) (p˂ 0.001; Fig. 4 ). The CVBM in the St group was 1.48-times thicker (0.807 ± 0.139 μm) than in WT mice, but only a 1.27-fold thicker (0.633 ± 0.164 μm) than ASC groups (p < 0.001; Fig. 4). 3.5. Antioxidants reduce Aβ deposition and hypoxia in hippocampal CA1 area and entorhinal cortex of female 3 × Tg-AD mice At 12 months of age, female 3 × Tg-AD mice have more plaques in the hippocampus and entorhinal cortex when compared to age-matched males (Figs. 5-7 and S2), There were around 30 plaques/field (Fig. 5A ) in the hippocampus of 3 × Tg-AD females when compared to 4.5 plaques/field in males (Fig. 7A) , which also covered more extended areas (7947 ± 1007 μm 2 in females versus males 2188 ± 510 μm 2 ). Furthermore, only females had plaques in the entorhinal cortex (Fig. 6A) , although the density (9 plaques/field) and the area covered (3416 ± 688 μm 2 ) were lower than in the hippocampus. However, we did not find tau pathology in hippocampus in any experimental group, neither in males nor in females (Fig. S3) .
Hypoxic areas were detected in the hippocampus and entorhinal cortex of 3 × Tg-AD females; these were associated with amyloid plaque deposition, with 40%-60% of plaques exhibiting hypoxia (Figs. 5 and 6 ). However, males did not show evidence of hypoxia despite developing a similar number of amyloid plaques in the hippocampus, as in the entorhinal cortex of females (Figs. 6 and 7) . These results suggest sex-related differences in AD progression in the 3 × Tg-AD animal model; whether hypoxia is developed in older males will be examined in future studies. There was no evidence of hypoxia in WT mice.
In female mice, Ub + ASC and ASC reduced the number and coverage area of plaques in the hippocampus (p < 0.01 and < 0.05, respectively) as compared to the St group (Fig. 5A, B) . There was no difference between Ub + ASC and ASC treatment groups. A similar trend was observed in the entorhinal cortex in terms of the number of plaques (p < 0.05 for ASC and Ub + ASC; Fig. 6A ) but not area covered by the plaques (Fig. 6B) . This was associated with a decrease in hypoxic area in the hippocampus of female mice (p < 0.001; Fig. 5D and 6D), with a greater reduction observed in hippocampus comparing Ub + ASC and ASC group (p < 0.01; Fig. 5C ). ASC and Ub + ASC treatments reduced significantly the area of senile plaques exhibiting hypoxia, both in hippocampus and entorhinal cortex, though Ub + ASC treatment was found to be more effective in the reduction of the hypoxic areas (Fig. 5C and 6 C) .
Antioxidants reduce Aβ plaque deposition in male 3 × Tg-AD mice
The number of plaques in the hippocampus of male 3 × Tg-AD mice Fig. 3 . Behavioral response exhibited in the corner test for neophobia, with horizontal and vertical activity ratio (A), latency of vertical activity (B), and total activity counts for horizontal (C) and vertical (D) activities Each diet-group had 5 males and 5 females. Data from different diets are split by gender. The statistical analysis showed that the factor sex was not significant with the same diet. Thus, data for both sexes were fused for subsequent statistical analysis using the Mann Whitney test to compare between treatments. St mice showed increased neophobia, that was ameliorated or reversed by treatments. Differences were regarded as statistically significant *p < 0.05, **p < 0.01 and ***p < 0.001. was 10-fold lower and the plaques were half as large as compared to matched 3 × Tg-AD females (Fig. 7A, B) . The number of plaques in the St group was around 75% and 50% higher than in the Ub + ASC (p < 0.01) and ASC (p < 0.05) groups, respectively. The mean area of plaques in the ASC group (2544 ± 2269 μm) did not differ from that in the St group (2188 ± 2105 μm) but it was reduced 2/3 in extension in the Ub + ASC group (795 ± 290 μm; p < 0.05) (Fig. 7B) . Interestingly, no hypoxic regions were observed in males at 12 months of age. The entorhinal cortex in males did not contain amyloid plaques or hypoxic areas under any experimental condition (Fig. S4) .
The expression of BACE1-a key protein in amyloidogenic processing of APP-was significantly increased in 3 × Tg-AD mice brains relative to WT (p < 0.001). The treatment with Ub + ASC strongly reduced (p < 0.001) the expression of this protein in comparison to St diet, but the BACE1 expression levels were still significantly higher compared to WT mice (p < 0.05; Fig. 8A ). BACE1 was mainly expressed in neurons (as shown by its co-localization) with the neuronal marker NeuN (Fig. 8B) . The 25% of the neurons in WT group were also labelled with the BACE1 antibody, but with a very dim intensity (Fig. 8) . The number of labelled neurons dramatically increased to 76%, in the St group and 60% for the ASC group with a very intense signal, suggesting that both, the number of neurons and the BACE1 expression per neuron is increased in the transgenic mice (Fig. 8B ). In the Ub + ASC group, the percentage of neurons expressing BACE1 protein (35%) was reduced significantly compared to St group (p < 0.001) and ASC (p < 0.01) and their staining was dimmer compared to that of St and ASC group (Fig. 8) .
The expression of BACE1 in astrocytes, identified as GFAP + cells, also increased significantly in St group compared to WT (p < 0.01) (Fig. 8 C, D) , but not in ASC and Ub + ASC groups. ASC diet reduced significantly the expression levels of BACE in GFAP+ cells (p < 0.05) and, although the Ub + ASC diet also showed the same trend, the reduction did not reach statistical significance (Fig. 8D) .
Quantification of microglia
To investigate the inflammatory status of the brain, we quantified microglia, which were detected in hippocampal CA1 areas lacking amyloid plaques by immunolabeling with anti-Iba1 antibody (Fig. S5) . The number of microglia was increased in a sex independent way in the The CVBM thickens in the transgenic 3 × Tg-AD mice and antioxidants prevent the CVBM thickening. Each diet-group had 5 males and 5 females. Data from different diets are split by gender. The statistical analysis showed that the factor sex was not significant with the same diet. Thus, data for both sexes were fused for subsequent statistical analysis using the Mann Whitney test to compare between treatments. Differences were regarded as statistically significant ***p < 0.001.
St group when compared to other groups (p < 0.05) (Fig. 9A) , indicating that the treatment with antioxidants reduced the number of microglia in transgenic 3 × Tg-AD mice. We have used the iNOS, a marker for the activated microglia phenotype, to characterize the physiological state of microglia in areas lacking of Aβ insult. The expression of iNOS exhibited sex-related differences, wherein females of St group showed higher expression levels than males when they were compared to WT (Fig. 9B, C) . In ASC and Ub + ASC male groups the percentage of iNOS-positive cells that co-localize with IBA1-positive cells significantly increased compared to WT (p < 0.05). St group also showed the same trend, but the increment did not reach statistical significance (Fig. 9B) . In females, this increment was significant between WT and St group (p < 0.01) as well as between WT and Ub + ASC group (p < 0.05) (Fig. 9C) .
Discussion
Markers of oxidative stress can be useful for diagnosing AD at the Fig. 5 . Colocalization of senile plaques with hypoxic areas in the CA1 of hippocampus in female mice. Senile plaques or hypoxic areas were not found in WT females. Aβ deposition and hypoxia in hippocampal CA1 area of female 3 × Tg-AD mice is ameliorated by treatments. The size of each diet group had 5 mice. Data were analyzed using Mann Whitney test comparing between groups. Differences were regarded as statistically significant *p < 0.05, **p < 0.01 and ***p < 0.001. earliest stages of disease. Oxidative stress damage occurs in MCI and AD patients, who exhibit diminished antioxidant defenses and elevated levels of oxidative damage markers (Nunomura et al., 2001; Puertas et al., 2012) ; these are also observed early in AD development in the 3 × Tg-AD mouse model and have been linked to Aβ-induced neurotoxicity (Resende et al., 2008; Torres-Lista et al., 2014) . Brain homogenates prepared from the cerebral cortex of female 3 × Tg-AD mice show evidence of oxidative stress (Resende et al., 2008) and oxidative status in neurons and glia in the cerebellum, hippocampus, and cerebral cortex is correlated with oxidative stress of peripheral leukocytes in mice displaying anxiety (Rammal et al., 2008) . Plasma levels of isoprostanes, which are specific markers of lipid peroxidation in vivo, were reportedly increased in Tg2576 mice (Pratico et al., 2001) . However, in our study, the levels of two classical markers of oxidative Fig. 6 . Colocalization of senile plaques with hypoxic areas in the entorhinal cortex in females. Senile plaques or hypoxic areas were not found in WT females. Hypoxia in entorhinal cortex of female 3 × Tg-AD mice is ameliorated by treatments, as well as the surface of senile plaques colocalizing with hypoxia. The size of each diet group had 5 mice. Data were analyzed using Mann Whitney test comparing between groups. Differences were regarded as statistically significant *p < 0.05, **p < 0.01 and ***p < 0.001. stress-MDA (lipid peroxidation) and protein carbonyl groups-were not elevated in the plasma of 12-month-old 3 × Tg-AD mice. Nevertheless, we observed that oxidative stress was increased in peripheral leukocytes of St relative to WT mice, suggesting that brain ROS levels were also higher, given that these are positively correlated (Rammal et al., 2008) . Dietary supplementation with Ub + ASC or ASC decreased peroxide concentration in leukocytes, which likely reduced oxidative stress in the brain.
In anxious mice it has been described that oxidative stress of peripheral leukocytes correlates with that found in both neuronal and glial cells in the cerebellum, hippocampus and cerebral cortex (Rammal et al., 2008) . In the present work, the behavioral assessment of neophobia using the corner test corroborated the increased neophobic response of 3 × Tg-AD mice (Gimenez-Llort et al., 2007) and provided evidence that this anxious-like immediate response to a new environment can be reversed by both Ub + ASC and ASC. Interestingly, the response pattern observed between groups shows a strong parallelism with that seen in oxidative stress of leukocytes. We have previously shown that these behaviors, which in the 3 × Tg-AD mice are found increased since prodromal stages of disease (2 months of age), correlate with the organometrics (relative size) (Gimenez-Llort et al., 2014), and several immunity functions of thymus and spleen (Gimenez-Llort et al., 2008) . Therefore, the present results provide further evidence supporting the correlation on behavior found between neophobia and anxiety with peripheral immunological system. The analysis and report of the effects of treatments on other aspects of behavior, such as cognition, that involve a high sex-dependent variability would require a bigger sample size to reach the statistical power established by guidelines (Gerlai, 1996) .
Since Ub is easily oxidized under an oxygen atmosphere, Kaneka has added ASC to the Ub formulation. The results we found in the ASC group were unexpected because mice can synthetize and maintain a high ASC concentrations in brain tissue. On the other hand, experimental manipulations that produce a moderate deficiency in ASC can accelerate amyloid plaque accumulation, which is likely modulated by oxidative stress pathways (Dixit et al., 2015) . In the J20 mouse model of AD fed with 1% (w/v) vitamin C solution for 6 months, oxidative stress and Aβ oligomer formation but not Aβ plaque burden in the brain were reduced (Murakami et al., 2011) . Furthermore, amyloid plaque accumulation in the cortex and hippocampus was increased in 5 × FAD mice lacking L-gulono-γ-lactone oxidase, the enzyme responsible for ascorbic acid biosynthesis; this effect was reversed by high Fig. 7 . Ubiquinol reduces the presence of βA plaques in CA1 of 3 × Tg-AD males. Senile plaques were not found in wt males. Hypoxic areas were absent in males. Neither senile plaques nor hypoxic areas were detected in entorhinal cortex. The size of each diet group had 5 mice. Data were analyzed using Mann Whitney test comparing between groups. Differences were regarded as statistically significant *p < 0.05, and ***p < 0.001. Fig. 8 . Immunofluorescence areas with BACE1 in hippocampus of 12 month-old mice. Each diet-group had 5 males and 5 females. Data from different diets are split by gender. The statistical analysis showed that the factor sex was not significant with the same diet. Thus, data for both sexes were fused for subsequent statistical analysis using the Mann Whitney test to compare between treatments. BACE1 expression in hippocampal CA1 area of female 3 × Tg-AD mice increased compared to WT and was ameliorated by treatments (A). The BACE staining was higher in transgenic mice, as well as the number of neurons expressing BACE1 protein. The number of neurons expressing BACE1 was reduced with the treatments (B). Also, the number of astrocytes expressing BACE1 was higher in the 3 × Tg-AD mice (C, D). Differences were regarded as statistically significant *p < 0.05, **p < 0.01 and ***p < 0.001. concentrations of ASC (3.3 g/l), although this treatment was no longer effective when the concentration exceeded the plasma ASC level in scurvy (Kook et al., 2014) . In the 3 × Tg-AD model, less ASC (0.06% in chow) administered mice from the age of 3 to 12 months abolished most of the symptoms of AD, including Aβ plaque burden, hypoxia, and CVBM thickness. AD patients have lower plasma and CSF ASC levels even with adequate nutrient intake (Riviere et al., 1998) ; a recent metaanalysis suggested that ASC intake can lower AD risk (Li et al., 2012) . It is possible that the decrease in ASC is due to higher ROS levels in the plasma of AD patients and the brain of AD animal models. We demonstrated that the first product of ascorbate oxidation-a free radical intermediate-was externally regenerated by the trans-plasma membrane redox system (Alcain et al., 1991) , which is CoQ-dependent (Arroyo et al., 2000) and is impaired by Aβ peptide accumulation in 3 × Tg-AD mice (Hyun et al., 2010) .
Adult 3 × Tg-AD mice exhibit many of the neuropathological features of AD, such as intraneuronal amyloid accumulation, development of amyloid plaques, and formation of neurofibrillary tangles by hyperphosphorylated tau (Oddo et al., 2003) . CVBM thickening with increased collagen-IV deposition has been reported in human AD (Kalaria and Pax, 1995; Claudio, 1996) , and 3 × Tg-AD mice exhibit increased CVBM thickening in the microvasculature of primary motor and pariotemporal cortices (Mehta et al., 2013a) and choroid plexus (GonzalezMarrero et al., 2015) . However, AD patients also show changes in cerebral microvasculature (with BBB leakage) and in CVBM thickness with consequent hypoperfusion of certain brain regions, which Fig. 9 . Immunofluorescence against Iba1 to determine the percentage of microglia and Iba1+ cells iNOS+ cells co-localization. Each diet-group had 5 males and 5 females. Data from different diets are split by gender. The statistical analysis showed that the factor sex was not significant with the same diet for the number of microglial cells. Thus, data for both sexes were fused for subsequent microglial-number statistical analysis using the Mann Whitney test to compare between treatments. (A). The number of microglia was increased in the St group as compared to all other groups (A). The activated microglia was determined by colocalization between Iba1+ cells with iNOS+ cells (B). Activation of microglia was sex-dependent (C and D) being more activation in transgenic females than WT, that was partially reversed by antioxidants (C). Differences were regarded as statistically significant *p < 0.05 and **p < 0.01. decreases oxygen and nutrient transport to neuronal parenchyma and leads to cognitive deficits (Kalaria and Pax, 1995; Farkas et al., 2000; Dai et al., 2009; Di Marco et al., 2015) . We did observe CVBM thickening in these mice at 12 months of age similar to previous observations (Bourasset et al., 2009; Mehta et al., 2013a Mehta et al., , 2013b Gonzalez-Marrero et al., 2015) . We demonstrated that this effect was abrogated by treatment with ASC and Ub + ASC, which could increase CBF and facilitate Aβ clearance (Farkas et al., 2000; Bourasset et al., 2009; Morris et al., 2014) , thereby slowing AD progression.
Although leakage of Evans's Blue dye has been reported in the cerebral microvasculature of Tg2576 mice (Ujiie et al., 2003) , we and others (Bourasset et al., 2009; Do et al., 2014) found no evidence of BBB disruption in the 3 × Tg-AD model. The BBB represents one of the greatest challenges for drug delivery to the central nervous system; brain uptake of memantine was decreased by 43% in 3 × Tg-AD relative to WT mice due to CVBM thickening (Mehta et al., 2013b) . Memantine has neuroprotective effects, and is a safe and effective treatment for moderate to severe AD symptoms. Our results provide new evidence that the BBB can be targeted by appropriate drugs and that collagen-IV deposition leading to CVBM thickening can be delayed by long-term antioxidant supplementation.
Abnormalities in capillary morphology are also linked to cerebral hypoperfusion, given that reductions in brain vascular volume are associated with CVBM thickening (Farkas et al., 2000; Bourasset et al., 2009) . Hypoperfusion in the brain parenchyma caused by a decrease in CBF increases the expression of hypoxia inducible factor 1-α, which in turn leads to upregulation of BACE1 (Zhang et al., 2007; Guglielmotto et al., 2009) . It has been reported that in healthy normally aging participants, higher Aβ load is associated with reduced CBF (Mattsson et al., 2014) . Also, oxidative stress resulting from CVBM thickening can increase BACE1 expression and amyloid plaque development in 3 × Tg-AD mice (Cai et al., 2012) . BACE1 is known to be regulated by oxidative stress and hypoxia (Apelt et al., 2004; Tamagno et al., 2002) and mild oxidative stress also induces BACE1 translocation to vesicles containing APP, where it promotes amyloidogenic processing (Tan et al., 2013) . BACE1 is widely considered a major determinant of brain vulnerability to Aβ deposition that is expressed mainly in neurons in the brain (Laird et al., 2005) . However, astrocytes can also express this enzyme under certain conditions related to chronic stress (Rossner et al., 2001 ) and in the affected brain tissue after middle cerebral artery occlusion (Hartlage-Rubsamen et al., 2003) . We have found and increment in the BACE1 expression in both pyramidal CA1 neurons and astrocytes when St group was compared to WT group, but the levels of co-localization between NeuN signal and BACE1 were around the 75% in CA1 pyramidal neurons compared to 4% co-localization in astrocytes, suggesting that neurons are the major source of Aβ deposition. Treatment with ASC and Ub + ASC greatly reduced the BACE1 expression, both in neurons and in astrocytes, which is consistent with the large reduction in the number of senile plaques and area covered by Aβ found in these dietary groups. It is worth noting that male and female mice were similar in terms of CVBM thickness and expression of BACE1 and oxidative stress markers in peripheral leukocytes. This implies that there are no sex differences in APP deposition and that any differences between male and females observed by us and others (Hirata-Fukae et al., 2008; Carroll et al., 2010) are related to sexual dimorphism in Aβ clearance, a hypothesis that is currently under investigation. It has been reported that the levels of the Aβ-degrading enzyme neprilysin are lower in female mice than in males, but this was observed in mice older than those examined in the present study (Hirata-Fukae et al., 2008) .
It has been described that the 3 × Tg-AD mice develop extracellular Aβ deposits prior to tangle formation. Extracellular Aβ deposits first became apparent in 6 month-old mice and tau pathology in 12 to 15 months of age in hippocampus (Oddo et al., 2003) . However, in this study we did not find phospho-tau immunoreactivity with the 2 antibodies used at 12 months of age. Also, it has been reported that at 12-14 months of age, female 3 × Tg-AD mice have more plaques in the hippocampus and entorhinal cortex as compared to age-matched males (Hirata-Fukae et al., 2008; Carroll et al., 2010) . Our results confirmed these data and revealed a sex-dependence in the start of plaque deposition. In different animal models of AD, dietary supplementation with CoQ10 delays neuronal atrophy and reduces Aβ deposition in APP, APP/PS1, and Tg19959 mice as a result of reduced oxidative stress Yang et al., 2008; Yang et al., 2010; Dumont et al., 2011) . Our findings using a different mouse model of AD confirmed that CoQ10 supplementation prevented amyloid deposition via downregulation of BACE1 expression. Increased oxidative stress in the brain also induces inflammation; it has been reported that systemic and local mild chronic inflammation can initiate a neurodegenerative cascade in AD. The inflammatory response during most chronic neurodegenerative diseases is mediated by microglia (Cunningham, 2013) , which accumulate at sites of plaque deposition in the brain (Gold and El Khoury, 2015) and evidenced a continuous increased production of inflammatory mediators including iNOS in AD models (Martin et al., 2017) . BACE1 expression is induced via modulation of nicotinamide adenine dinucleotide phosphate oxidase, and consequently enhanced Aβ deposition and hypoxia (Cunningham, 2013) . Our results show that females exhibited an enhanced susceptibility to express the activated phenotype than males in the 3 × Tg-AD model. It has been reported that inflammatory microglia are poor phagocytes of Aβ (Streit and Xue, 2012) , which can facilitate a major Aβ accumulation, mainly in females. Our data suggest that dietary supplementation with antioxidant such as ASC alone or in conjunction with Ub reduces the chronic inflammation and AD progression, likely by inhibiting BACE1 expression and reducing hypoxia.
The CA1 region of the hippocampus is susceptible to damage from even brief episodes of ischemia, which can irreversibly block synaptic transmission and cause neuronal damage (Kreisman et al., 2000) . Prolonged hypoxia can inhibit glutamate uptake in astrocytes and may contribute to glutamate excitotoxicity (Kohmura et al., 1990; Dallas et al., 2007) . Amyloid plaque accumulation is more extensive in the hippocampus than in other brain regions in both male and female AD patients; increased Aβ deposition is linked to lower CBF (Mattsson et al., 2014) . It was recently reported that chronic cerebral hypoperfusion induced Aβ accumulation in mice (Wang et al., 2016; Zhai et al., 2016) , which in turn caused hypoxia. We found here that although male and female 3 × Tg-AD mice had a similar numbers and coverage area of amyloid plaques (i.e., in the hippocampus in males vs the entorhinal cortex in females), male mice showed no evidence of hypoxia. The background strain of 3 × Tg-AD (C57BL/6) showed no sex differences in cardiovascular parameters when standardized by body weight . Increased Aβ deposition is correlated with microvascular impairment and endothelial cell damage (Chami and Checler, 2012; Dorr et al., 2012) . We previously reported that exogenous CoQ10 protects human endothelial cells from Aβ uptake and oxidative stress-induced injury (Duran-Prado et al., 2014) ; the results of the present study indicate that it has similar effects in neurons.
In summary, we hypothesize that in the 3 × Tg-AD mice before AD neuropathology is evident, the early increment in the brain oxidative stress (Resende et al., 2008) could contribute to the thickening of the CVBM, as it has been described for the glomerular basement membrane thickening in diabetic nephropathy , reducing the oxygen supply to the brain (Fig. 10) . The hypoperfusion induces the upregulation of BACE1, generating Aβ and forming the amyloid plaques. The increment in Aβ deposition enhances the oxidative stress and initiates a vicious cycle driving to the formation of hypoxic areas which in turn leads to upregulation of BACE1 in these hypoxic regions overstimulating the Aβ deposition. Diets supplemented with antioxidants, Ub + ASC or ASC, keep ROS levels in a range similar to WT mice and are able to mitigate CVBM thickening, BACE1 upregulation, delay the formation of amyloid plates and reduce the hypoxic areas.
The major limitation of this study is that it used an animal model of AD; as such, the significance of our findings for humans remains unclear. Nonetheless, our results provide evidence for the therapeutic efficacy of Ub and other antioxidants for AD treatment. A model summarizing our results is shown in Fig. 10 . Before the appearance of AD symptoms, an increase in ROS levels in female 3 × Tg-AD mice induced CVBM thickening, reducing oxygen supply to the brain. The resultant hypoperfusion caused a translocation of BACE1, leading to Aβ accumulation and formation of amyloid plaques followed by hypoxia at later stages. We expect that the same process occurs in male mice, albeit at a later age.
Conclusions
The results of the current study demonstrate that Ub and ASC can modulate the cerebrovascular response to hypoxia and prevent BACE1 expression and Aβ deposition while reducing the thickness of the CVBM during early asymptomatic stages of AD. In addition, we showed that 3 × Tg-AD mice recapitulate features of AD pathology and can be a useful model for investigating the effectiveness of therapeutic agents in restoring endothelial cell and BBB integrity.
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